BioMedha is a UK-based CRO providing bioscience expertise to the global drug discovery industry. We are industry-experienced, in vitro biology-focused scientists and can add significant value to our client’s programmes by undertaking key elements of the early stage drug discovery process. Our bespoke services include assay development, screening, biochemical assays, phenotypic assays, functional and expression studies, drug combination studies, proof-of-concept studies, MOA studies and indicative discovery toxicology studies.

We serve clients from pharma and biotech as well as virtual companies and academic institutions, and have considerable in vitro drug discovery experience in oncology, CNS, inflammation, diabetes and metabolic disorders. We provide bespoke, issue-specific, high-quality services tailored to client objectives at the most competitive pricing.

Our mission is to support accelerating your drug discovery programmes from hypothesis to candidate selection.